Alaunos Therapeutics, Inc. - Common stock (TCRT)
CUSIP: 98973P309
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common stock
- Shares outstanding
- 2,198,384
- Total 13F shares
- 108,542
- Share change
- +43,318
- Total reported value
- $349,893
- Price per share
- $3.23
- Number of holders
- 26
- Value change
- +$139,293
- Number of buys
- 8
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 98973P309?
CUSIP 98973P309 identifies TCRT - Alaunos Therapeutics, Inc. - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98973P309:
Top shareholders of TCRT - Alaunos Therapeutics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Robert W. Postma |
13D/G
|
Postma Robert W |
9%
|
199,796
|
$615,372 | $0 | 24 Jun 2025 | |
| Kevin S. Boyle Sr. |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
798,236
|
$111,993 | — | 01 Sep 2023 | |
| BlackRock, Inc. |
13F
|
Company |
0.97%
|
21,353
|
$51,461 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.95%
|
20,972
|
$51,172 | — | 30 Sep 2025 | |
| Raffaele Baffa |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
280,645
|
$39,374 | — | 17 May 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.72%
|
15,791
|
$38,539 | — | 30 Sep 2025 | |
| Ferdinand Groenewald |
3/4/5
|
Vice President of Finance |
—
mixed-class rows
|
14,775
mixed-class rows
|
$30,924 | — | 18 Aug 2025 | |
| Heidi Hagen |
3/4/5
|
Director |
—
class O/S missing
|
145,889
|
$20,468 | — | 02 Sep 2021 | |
| Christopher Bowden |
3/4/5
|
Director |
—
mixed-class rows
|
144,167
mixed-class rows
|
$6,197 | — | 22 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
1,684
|
$4,058 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.07%
|
1,633
|
$3,936 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
1,533
|
$3,695 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.05%
|
1,165
|
$2,813 | — | 30 Sep 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
300
|
$723 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
183
|
$441 | — | 30 Sep 2025 | |
| Blue Trust, Inc. |
13F
|
Company |
0.01%
|
135
|
$325 | — | 30 Sep 2025 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
92
|
$222 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
89
|
$214 | — | 30 Sep 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
70
|
$169 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
50
|
$121 | — | 30 Sep 2025 | |
| Asset Dedication, LLC |
13F
|
Company |
0%
|
46
|
$111 | — | 30 Sep 2025 | |
| Key FInancial Inc |
13F
|
Company |
0%
|
24
|
$60 | — | 30 Sep 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
24
|
$58 | — | 30 Sep 2025 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
23
|
$55 | — | 30 Sep 2025 | |
| NBC SECURITIES, INC. |
13F
|
Company |
0%
|
20
|
$48 | — | 30 Sep 2025 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
19
|
$46 | — | 30 Sep 2025 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
10
|
$24 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
6
|
$15 | — | 30 Sep 2025 | |
| Wealthspire Advisors, LLC |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Sep 2025 | |
| Truvestments Capital LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 30 Sep 2025 | |
| Eleanor de Groot |
3/4/5
|
EVP, Operations |
—
class O/S missing
|
350,000
|
— | — | 30 Mar 2022 | |
| Abhishek K. Srivastava |
3/4/5
|
Vice President, Technical Operations |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| Drew Deniger |
3/4/5
|
Vice President, Research and Development |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| Michael Wong |
3/4/5
|
Vice President, Finance |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| James Huang |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 06 Jun 2023 | |
| Mary Thistle |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 06 Jun 2023 | |
| Holger Weis |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
13,676
|
— | — | 18 Aug 2025 | |
| Robert Hofmeister |
3/4/5
|
Director |
—
class O/S missing
|
12,800
|
— | — | 06 Jun 2024 | |
| Dale Curtis Hogue Jr. |
3/4/5
|
Chief Executive Officer, Interim, Director |
—
class O/S missing
|
3,000
|
— | — | 29 Mar 2025 | |
| Melinda Lackey |
3/4/5
|
Legal & Administration |
—
class O/S missing
|
1,000
|
— | — | 29 Mar 2025 |
Institutional Holders of Alaunos Therapeutics, Inc. - Common stock (TCRT) as of Q4 2025
As of 31 Dec 2025,
Alaunos Therapeutics, Inc. - Common stock (TCRT) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,542 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, HRT FINANCIAL LP, MORGAN STANLEY, UBS Group AG, Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., and CIBC Private Wealth Group LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
24
Q4 2025 holders
26
Holder diff
2
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.